The Special Investment Facilitation Council (SIFC), in collaboration with the Ministry of National Health Services, Regulations and Coordination (NHSR&C) and the Drug Regulatory Authority of Pakistan (DRAP), would host the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference 2026 on July 17-18 in the capital to promote bilateral investment, industrial cooperation and technological collaboration in the pharmaceutical and healthcare sectors.
SIFC to host Pakistan–China pharma, healthcare investment conference on July 17-18
ISLAMABAD, Jul 13 (APP):The Special Investment Facilitation Council (SIFC), in collaboration with the Ministry of National Health Services, Regulations and Coordination (NHSR&C) and the Drug Regulatory Authority of Pakistan (DRAP), would host the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference 2026 on July 17-18 in the capital to promote bilateral investment, industrial cooperation and technological collaboration in the pharmaceutical and healthcare sectors.
The conference was aimed to strengthen Pakistan-China economic cooperation by promoting investment, innovation and strategic partnerships in the pharmaceutical, healthcare and biotechnology industries while providing a dedicated platform for business engagement between the two countries, said a press release here on Monday.
The event would bring together leading Pakistani pharmaceutical, healthcare and biotechnology companies with Chinese investors, manufacturers, technology providers and industry leaders to explore commercial partnerships, investment opportunities and cross-border business collaboration.
Delegates would participate in structured business-to-business (B2B) meetings, networking sessions and investment discussions focusing on joint ventures, technology transfer, contract manufacturing, research collaboration and local production partnerships aimed at modernizing Pakistan’s healthcare ecosystem and strengthening the competitiveness of its pharmaceutical industry.
The press release said SIFC, through its whole-of-government approach, continued to facilitate foreign direct investment, strengthen institutional coordination and connect international investors with Pakistan’s high-potential sectors.
The pharmaceutical and healthcare industries remain among SIFC’s priority sectors due to their strong potential for industrial expansion, export growth, technological advancement and employment generation.
It added that the conference was expected to further reinforce the longstanding strategic partnership between Pakistan and China by encouraging long-term industrial collaboration and unlocking new investment opportunities that contribute to sustainable economic development and shared prosperity.
